Watchlist Price Alert

Bellicum Pharmaceuticals ... (BLCM)

NASDAQ: BLCM · Real-Time Price · USD

0.07

-0.01 (-12.61%)

At close: Mar 04, 2024, 7:59 PM

Bellicum Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-24.97M	-9.71M	-7.72M	-112.48M	-98.04M	-91.78M	-69.24M
Depreciation & Amortization	11K	138K	1.87M	8.51M	6.7M	3.56M	2.31M
Stock-Based Compensation	2.61M	3.44M	5.03M	7.34M	13.82M	13.57M	12.34M
Other Working Capital	-1.86M	-1.55M	-6.25M	-5.77M	-1.1M	4.01M	47K
Other Non-Cash Items	-1.96M	23K	964K	1.69M	610K	672K	303K
Deferred Income Tax	n/a	-14.65M	-48.63M	24.28M	104K	2.08M	549K
Change in Working Capital	-1.47M	-2.35M	-8.16M	-6.9M	2.02M	-1.09M	3.31M
Operating Cash Flow	-25.78M	-23.11M	-56.65M	-77.57M	-74.78M	-72.98M	-50.44M
Capital Expenditures	-21K	-7K	-625K	-522K	-1.62M	-12.13M	-7.22M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	-59.34M	-54.9M	-33.28M
Sales Maturities Of Investments	n/a	n/a	n/a	49.38M	71.36M	63.74M	42.55M
Other Investing Acitivies	n/a	900K	14.71M	n/a	n/a	39K	n/a
Investing Cash Flow	-21K	893K	14.08M	48.86M	10.41M	-3.25M	2.05M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	32.87M	-14.24M	74.09M	68.11M	78.49M	20.93M
Financial Cash Flow	n/a	32.87M	-14.24M	74.09M	68.11M	78.49M	20.93M
Net Cash Flow	-25.82M	10.66M	-56.82M	45.15M	3.64M	2.25M	-27.46M
Free Cash Flow	-25.8M	-23.11M	-57.27M	-78.09M	-76.4M	-85.12M	-57.66M